Pharmabiz

GSK’s Nucala receives positive CHMP opinion for treatment of chronic obstructive pulmonary disease

GSK’s Nucala receives positive CHMP opinion for treatment of chronic obstructive pulmonary disease: London, UK Monday, December 15, 2025, 16:00 Hrs [IST] GSK plc announced that ...
Pharmabiz

Akums introduces enhanced gabapentin ER formulation powered by RetenEx Technology for PHN management

Akums introduces enhanced gabapentin ER formulation powered by RetenEx Technology for PHN management: Our Bureau, Chennai Monday, December 15, 2025, 15:45 Hrs [IST] Akums Drugs & ...
Pharmabiz

NIH clinical trial shows expanded umbilical cord blood transplant achieves 94% survival in severe aplastic anaemia patients

NIH clinical trial shows expanded umbilical cord blood transplant achieves 94% survival in severe aplastic anaemia patients: Maryland Monday, December 15, 2025, 15:00 Hrs [IST] A ...
Pharmabiz

University of Western Australia with AMTZ to position Visakhapatnam as a major Indo-Pacific hub for MedTech innovation

University of Western Australia with AMTZ to position Visakhapatnam as a major Indo-Pacific hub for MedTech innovation: Our Bureau, Bengaluru Monday, December 15, 2025, 14:15 Hrs ...
Pharmabiz

Ebekme with AHPI to set up Co-Skills Hub dedicated exclusively to hospital workforce training

Ebekme with AHPI to set up Co-Skills Hub dedicated exclusively to hospital workforce training: Our Bureau, Bengaluru Monday, December 15, 2025, 13:40 Hrs [IST] Ebekmed, in collabo ...
Pharmabiz

EMA committee recommends approval of STADA & Bio-Thera’s golimumab biosimilar Gotenfia

Thera’s golimumab biosimilar Gotenfia: Bad Vilbel, Germany Monday, December 15, 2025, 14:00 Hrs [IST] Global specialty, generic ...
Pharmabiz

Biocon launches its glucagon-like peptide-1, liraglutide in Netherlands

Biocon launches its glucagon-like peptide-1, liraglutide in Netherlands: Our Bureau, Bengaluru Monday, December 15, 2025, 13:30 Hrs [IST] Biocon has launch of its GLP-1 peptide, l ...
Pharmabiz

Aflibercept 8 mg recommended for marketing authorization in EU for third retinal indication

Aflibercept 8 mg recommended for marketing authorization in EU for third retinal indication: Berlin Monday, December 15, 2025, 13:00 Hrs [IST] The Committee for Medicinal Products ...
Pharmabiz

Groundbreaking prostate cancer trial launches in the UK

A groundbreaking international trial for treating prostate cancer has launched in the UK. The trial is sponsored by US company PROCEPT BioRobotics and supported by the National Institute for Health ...
Pharmabiz

EMA committee recommends approval of an expanded indication for Merck’s Winrevair in adults with pulmonary arterial hypertension

EMA committee recommends approval of an expanded indication for Merck’s Winrevair in adults with pulmonary arterial hypertension: Rahway, New Jersey Monday, December 15, 2025, 1 ...
Pharmabiz

9th Annual Pharma Project & Portfolio Management conference to be held on February 4, 5 & 6, 2026, in Goa

Annual Pharma Project & Portfolio Management conference to be held on February 4, 5 & 6, 2026, in Goa: Our Bureau, Mumbai Monday, December 15, 2025, 09:00 Hrs [IST] The pharma ...
Pharmabiz

UK and Singapore launch a regulatory innovation corridor to speed up access to breakthrough health technologies

Patients in the UK and Singapore could benefit sooner from major medical advances as the UK and Singapore launch a new regulatory innovation corridor to fast-track the most promising healthcare ...